Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
5.01
+0.20 (4.16%)
At close: May 12, 2025, 4:00 PM
5.00
-0.01 (-0.20%)
After-hours: May 12, 2025, 5:57 PM EDT
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $246.84 million as of May 12, 2025. Its market cap has increased by 39.02% in one year.
Market Cap
246.84M
Enterprise Value
157.66M
1-Year Change
39.02%
Ranking
Category
Stock Price
$5.01
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $246.84M, an increase of 11.00%. That is a compound annual growth rate of 2.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 236.99M | -35.72% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |